ALCAM and lobular neoplasia: Indeed, we have assayed serum and urine ALCAM in the same cohort of subjects (data not shown), where we find that uALCAM was able to significantly discriminate active LN from other patients with SLE (AUC values > 92%), whereas sALCAM failed to do so.